x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

touchPODCAST

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare

science

All Episodes

33:13

Novel targeted therapies for NSCLC: Exploring HER2...

touchPODCAST ·

2021/10/26

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of experts discuss the latest clinical research in HER2 dysregulation and potential HER2-targeted therapies in NSCLC. The experts Prof. Egbert Smit – Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands Dr Jarushka Naidoo – Beaumont Hospital, Dublin, Ireland Dr Katerina Politi – Yale School of Medicine, New Haven, CT, US This touchPODCAST is for HCPs only. This activity is funded by an unrestricted

en

37:51

Experts discuss non-steroidal MRAs for the treatment...

touchPODCAST ·

2021/10/25

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to leading experts discuss why the treatment landscape for patients with T2D and CKD requires novel therapies; why non-steroidal MRAs are being investigated in these patients and the latest clinical data; and how non-steroidal MRAs might fit into the current T2D and CKD treatment paradigm. The experts Prof. Christoph Wanner, University Hospital of Würzburg, Würzburg, Germany Dr Javed Butler, University of Mississippi Medical Center, Jackson, MS,

en

37:48

Immunotherapy and evolving approaches for basal cell...

touchPODCAST ·

2021/10/18

touchPANEL DISCUSSION for touchONCOLOGY Listen to leading experts discuss evolving treatment options for patients with EGFR-mutant NSCLC, and the rationale for biomarker testing in both early-stage and metastatic disease to determine best treatment approaches, taking in recently presented data from the World Lung Cancer Congress and ESMO Congress 2021. The experts Dr Pasi Jӓnne, Dana-Farber Cancer Institute, Boston, MA, USA Dr Thanyanan Reungwetwattana, Ramathibodi Hospital, Bangkok, Thailand Dr

en

19:43

MDT and patient perspectives on real-world use of...

touchPODCAST ·

2021/10/13

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient discuss real-world use of antihyperglycemic therapies to achieve an effective combination of glycemic control, weight loss and cardiovascular benefits. The multidisciplinary team and patient Diabetes nurse practitioner: Dr Shannon Idzik, USA Primary care specialist: Professor Stewart Harris, Canada Patient: Tammie Snowden, USA This touchPODCAST is for HCPs only. This activity is funded by an

en

16:32

MDT and patient perspectives on antihyperglycemic...

touchPODCAST ·

2021/10/13

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient explore the importance of weight loss in T2D; GLP-1 RAs and SGLT2is and their association with weight loss; plus the patient’s experience of using a GLP-1 RA to manage their T2D and obesity. The multidisciplinary team and patient Endocrinologist: Professor Dr med Michael Nauck, Germany Primary care specialist: Professor Stewart Harris, Canada Patient: Tammie Snowden, USA This touchPODCAST is for HCPs

en

12:37

Perspectives on the mechanism linking obesity with T2D

touchPODCAST ·

2021/10/13

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the mechanism linking obesity with T2D and share their observations from the clinic on the course of disease from obesity to T2D. The multidisciplinary team Primary care specialist: Professor Stewart Harris, Canada Endocrinologist: Professor Dr med Michael Nauck, Germany This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This

en

01:02:47

Frontline IO for advanced NSCLC: Updates from ASCO...

touchPODCAST ·

2021/10/06

touchCONGRESS for touchRESPIRATORY Listen to Prof. Edward Garon (USA) cover key data presented at ASCO and ESMO 2021 on optimizing frontline immunotherapy for advanced NSCLC, including expert insights and interpretation from Dr Raffaele Califano (UK) and Prof. Anne-Marie Dingemans (The Netherlands). OVERVIEW Data review with Prof. Garon (0:00) Expert interview with Dr Califano, Prof. Dingemans and Prof. Garon, answering the questions below INTERVIEW QUESTIONS Based on data recently presented at

en

01:02:43

Frontline IO for advanced NSCLC: Updates from ASCO...

touchPODCAST ·

2021/10/06

touchCONGRESS for touchONCOLOGY Listen to Prof. Edward Garon (USA) cover key data presented at ASCO and ESMO 2021 on optimizing frontline immunotherapy for advanced NSCLC, including expert insights and interpretation from Dr Raffaele Califano (UK) and Prof. Anne-Marie Dingemans (The Netherlands). OVERVIEW Data review with Prof. Garon (0:00) Expert interview with Dr Califano, Prof. Dingemans and Prof. Garon, answering the questions below INTERVIEW QUESTIONS Based on data recently presented at ASCO21

en

42:15

Type 2 diabetes experts discuss achieving...

touchPODCAST ·

2021/09/30

touchIN CONVERSATION for touchENDOCRINOLOGY Listen to Dr Vincent Woo in conversation with Dr Joanna Van. They respond to questions submitted by the HCP audience and provide their expert insights on the key considerations for achieving individualized glycemic targets in patients with type 2 diabetes. This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from Eli Lilly. The activity is provided by touchIME. For further information visit our website:

en

13:07

Investigating immunotherapies for endometrial cancer:...

touchPODCAST ·

2021/09/23

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss how patients with endometrial cancer should be tested to determine suitability for PD-1/PD-L1 inhibitor therapy. The multidisciplinary team Gynaecological oncologist: Prof. Nicole Concin Pathologist: Dr Alicia León-Castillo This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from GlaxoSmithKline. This activity is provided by touchIME. For further

en

14:50

Investigating immunotherapies for endometrial cancer:...

touchPODCAST ·

2021/09/23

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team review a patient profile and describe how they would determine suitability for PD-1/PD-L1 inhibitor therapy. The multidisciplinary team Gynaecological oncologist: Prof. Nicole Concin Medical oncologist: Dr Antonio González-Martín Pathologist: Dr Alicia León-Castillo This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from GlaxoSmithKline. This activity is

en

13:18

Investigating immunotherapies for endometrial cancer:...

touchPODCAST ·

2021/09/23

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the latest data on PD-1/PD-L1 inhibitors and what they mean for patients with EC. The multidisciplinary team Gynaecological oncologist: Prof. Nicole Concin Medical oncologist: Dr Antonio González-Martín This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from GlaxoSmithKline. This activity is provided by touchIME. For further information visit our

en

36:19

Immunotherapy and evolving approaches for basal cell...

touchPODCAST ·

2021/09/17

touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how novel immunotherapeutic approaches within the emerging clinical study landscape may improve patient care. The experts Prof. Axel Hauschild, University Hospital Schleswig-Holstein, Kiel, Germany Dr Emily Ruiz, Brigham and Women’s Hospital, Boston, MA, USA Prof. Ketty Peris, Catholic University of Rome, Rome, Italy This touchPODCAST is for HCPs

en

36:20

Immunotherapy and evolving approaches for basal cell...

touchPODCAST ·

2021/09/17

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how novel immunotherapeutic approaches within the emerging clinical study landscape may improve patient care. The experts Prof. Axel Hauschild, University Hospital Schleswig-Holstein, Kiel, Germany Dr Emily Ruiz, Brigham and Women’s Hospital, Boston, MA, USA Prof. Ketty Peris, Catholic University of Rome, Rome, Italy This touchPODCAST is for HCPs

en

13:38

What is the long-term picture for patients with...

touchPODCAST ·

2021/09/15

touchMDT for touchONCOLOGY Listen to a medical oncologist and an oncology nurse practitioner discuss how to involve the patient in treatment decisions and the role of the multidisciplinary team in keeping abreast of the latest data. The multidisciplinary team Medical oncologist: Dr David Planchard, France Oncology nurse practitioner: Ms Beth Sandy, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly

en

14:15

What are the implications of adjuvant therapy data on...

touchPODCAST ·

2021/09/15

touchMDT for touchONCOLOGY Listen to a medical oncologist and a pathologist discuss the benefits of biomarker testing in early and locally advanced NSCLC. The multidisciplinary team Medical oncologist: Dr David Planchard, France Molecular pathologist: Prof. Albrecht Stenzinger, Germany This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further

en

16:39

How is the advent of adjuvant therapy in NSCLC...

touchPODCAST ·

2021/09/15

touchMDT for touchONCOLOGY Listen to a medical oncologist, a pulmonologist and a thoracic surgeon as they assess the suitability of a patient with NSCLC for surgery and expanding treatment options. The multidisciplinary team Medical oncologist: Dr David Planchard, France Pulmonologist: Prof. Johan Vansteenkiste, Belgium Thoracic surgeon: Dr Masahiro Tsuboi, Japan This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is

en

35:42

Patient education, evidence-based treatment and...

touchPODCAST ·

2021/07/29

touchPANEL DISCUSSION for touchCARDIO Listen to leading experts discuss how patients can be best supported following a diagnosis of HFrEF, how to implement evidence-based therapies into practice including the potential impact of emerging therapies on treatment selection, and the role of biomarkers in diagnosing, monitoring and determining treatment course for individuals with HFrEF. The experts Prof. Piotr Ponikowski, Wrocław Medical University, Wrocław, Poland Prof. Adriaan A Voors, University

en

01:04:10

Highlights from EHA2021 Virtual 2021: Focus on MDS...

touchPODCAST ·

2021/07/20

touchCONGRESS for touchONCOLOGY Listen to Prof. Uwe Platzbecker (Germany) cover key data presented at EHA2021 Virtual on new and emerging treatments for the improvement of outcomes in higher-risk MDS and newly diagnosed AML, including expert insights and interpretation from Prof. Valeria Santini (Italy) and Prof. Andrew Wei (Australia). This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent educational grant from Novartis. The content was led by

en

19:02

Perspectives on the latest data for novel...

touchPODCAST ·

2021/07/20

touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia The multidisciplinary team Primary care physician: Dr Yassir Javaid, UK Cardiologist: Dr Constantine Kosmas, USA Endocrinologist: Professor Lawrence Leiter, Canada This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG,

en

532 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter